The Block Firm is investigating a potential class action lawsuit against MiMedx Group, Inc., the maker of the AXIOFILL wound treatment. According to a recently released FDA Warning Letter, MiMedx Group has been selling AXIOFILL without proper approval for safety and efficacy. Additionally, FDA determined that MiMedx Group has been violating federal safety standards known as Current Good Manufacturing Practices or CGMPs, which help ensure that medical products are sterile and safe.
When companies violate federal drug and device safety rules, they put patients at risk and distort the market for health care.
If you were exposed to AXIOFILL, you may have a claim for compensation. Please contact the experienced attorneys at The Block Firm to learn more about your potential legal rights.
Let us help you
February 16, 2024
The Block Firm Receives Preliminary Approval of $46.5 Million Class Action Settlement
January 10, 2024
The Block Firm Investigates a Potential Class Action Against MiMedx Group, Inc.
December 11, 2023
Warning: SugarMD Advanced Glucose Support is subject to a recall due to “hidden drug ingredients” that can be harmful to health
November 30, 2023
The Block Firm Investigates Reports of Lead and Other Toxins in Children’s Snacks
November 17, 2023
AppleCare: Is Apple still charging you to cover a device they know you no longer use?
November 9, 2023
Georgia Tenants: You Have a Right to Safe Housing and Here is Why
October 24, 2023
Consumer Protection Victory: The Block Firm Successfully Protects Bank Customers from Financial Scams
August 9, 2023